Northwest & Ethical Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,902
Closed -$68.7K 528
2024
Q3
$68.7K Sell
9,902
-5,100
-34% -$40K ﹤0.01% 477
2024
Q2
$117K Buy
15,002
+1,800
+14% +$13.3K ﹤0.01% 436
2024
Q1
$93.7K Buy
+13,202
New +$87.3K ﹤0.01% 446

Other funds holding GDRX

Northwest & Ethical Investments's GDRX Position: Q4 2024 in Review

Northwest & Ethical Investments sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 9,902 shares — an estimated $68.7K sold.

Northwest & Ethical Investments first reported a position in GDRX in Q1 2024 and held it in 3 quarters. The position peaked at $117K in Q2 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Northwest & Ethical Investments reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Northwest & Ethical Investments sold 9,902 GoodRx Holdings shares in Q4 2024, an estimated $68.7K.
  • Northwest & Ethical Investments first reported a position in GoodRx Holdings in Q1 2024 and held it in 3 quarters.
  • Northwest & Ethical Investments's GoodRx Holdings position peaked at $117K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Northwest & Ethical Investments's 13F filing for Q4 2024, filed 11 Feb 2025.